NCT01369316

Brief Summary

That Circumferential Submucosal Incision Endoscopic Mucosal Resection (CSI-EMR) will be at least as safe but more effective than conventional EMR for injection assisted EMR of large laterally spreading tumour and sessile polyps of the colon.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 8, 2011

Completed
8.8 years until next milestone

Study Start

First participant enrolled

March 9, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2020

Completed
Last Updated

March 27, 2025

Status Verified

March 1, 2025

Enrollment Period

Same day

First QC Date

June 6, 2011

Last Update Submit

March 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy of CSI EMR (Rates of en-bloc resection, recurrence rates)

    3 months

Study Arms (2)

Circumferential Submucosal Incision Resection

EXPERIMENTAL
Procedure: Circumferential Submucosal Incision Resection

Endoscopic Mucosal Resection

ACTIVE COMPARATOR

Patients randomised into this arm will receive the conventional treatment Endoscopic Mucosal Resection in which the sessile lesion is injected and snared by piecemeal technique.

Procedure: Endoscopic Mucosal Resection

Interventions

The patient is randomized, if in the active arm the procedure will continue as Circumferential Submucosal Incision Endoscopic Mucosal Resection.

Circumferential Submucosal Incision Resection

Patients randomised into this Intervention type will have Endoscopic Mucosal Resection performed

Endoscopic Mucosal Resection

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Can give informed consent to trial participation
  • Age greater than 18
  • Adenomas that have not have previously been attempted for resection (i.e. naïve lesions)
  • Adenoma size greater than 20 mm

You may not qualify if:

  • Age less than 18
  • Previous resection or attempted resection of target adenoma lesion
  • Pregnant patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Westmead Hospital

Westmead, New South Wales, 2145, Australia

Location

MeSH Terms

Conditions

Colonic Polyps

Interventions

Endoscopic Mucosal Resection

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Michael J Bourke

    Westmead Hospital - Endoscopy Unit

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr Michael Bourke

Study Record Dates

First Submitted

June 6, 2011

First Posted

June 8, 2011

Study Start

March 9, 2020

Primary Completion

March 9, 2020

Study Completion

March 9, 2020

Last Updated

March 27, 2025

Record last verified: 2025-03

Locations